Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Details)

v3.8.0.1
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Mar. 31, 2018
Mar. 31, 2017
Basic and diluted numerator:        
Net loss attributable to iBio, Inc. $ (3,962) $ (3,913) $ (11,687) $ (10,203)
Preferred stock dividends 64 26 195 26
Net loss available to iBio, Inc. stockholders $ (4,026) $ (3,939) $ (11,882) $ (10,229)
Basic and diluted denominator:        
Weighted-average common shares outstanding 115,449 89,109 102,473 89,109
Per share amount $ (0.03) $ (0.04) $ (0.12) $ (0.11)